Crinetics Pharmaceuticals Inc (CRNX)
32.72
+0.92
(+2.89%)
USD |
NASDAQ |
Dec 01, 16:00
32.72
0.00 (0.00%)
After-Hours: 20:00
Crinetics Pharmaceuticals Price: 32.72 for Dec. 1, 2023
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 30, 2023 | 32.04 | 32.94 | 31.35 | 31.80 | 781747.0 |
Nov 29, 2023 | 31.55 | 32.55 | 31.46 | 32.03 | 508849.0 |
Nov 28, 2023 | 31.99 | 31.99 | 30.87 | 31.35 | 384823.0 |
Nov 27, 2023 | 31.81 | 32.10 | 31.15 | 31.81 | 668898.0 |
Nov 24, 2023 | 30.50 | 32.87 | 30.50 | 31.99 | 731699.0 |
Nov 22, 2023 | 30.09 | 30.89 | 29.72 | 30.74 | 593158.0 |
Nov 21, 2023 | 30.15 | 30.66 | 29.90 | 29.94 | 471117.0 |
Nov 20, 2023 | 30.06 | 31.23 | 29.23 | 30.22 | 607629.0 |
Nov 17, 2023 | 28.62 | 30.23 | 28.50 | 29.99 | 844597.0 |
Nov 16, 2023 | 28.84 | 28.89 | 27.54 | 28.34 | 571717.0 |
Nov 15, 2023 | 28.47 | 30.15 | 28.47 | 28.88 | 699652.0 |
Nov 14, 2023 | 29.55 | 30.11 | 28.46 | 28.65 | 1.012M |
Nov 13, 2023 | 26.84 | 28.30 | 25.91 | 28.28 | 505405.0 |
Nov 10, 2023 | 26.69 | 27.11 | 25.75 | 26.93 | 595430.0 |
Nov 09, 2023 | 28.78 | 29.00 | 26.45 | 26.69 | 715979.0 |
Nov 08, 2023 | 29.09 | 29.56 | 26.98 | 28.45 | 1.479M |
Nov 07, 2023 | 30.22 | 30.23 | 28.00 | 29.52 | 1.084M |
Nov 06, 2023 | 30.67 | 31.30 | 30.44 | 30.49 | 1.232M |
Nov 03, 2023 | 29.88 | 31.41 | 29.58 | 30.70 | 1.659M |
Nov 02, 2023 | 29.80 | 30.18 | 28.73 | 29.20 | 562178.0 |
Nov 01, 2023 | 29.05 | 29.78 | 28.14 | 29.55 | 779956.0 |
Oct 31, 2023 | 28.65 | 29.31 | 28.00 | 29.29 | 714059.0 |
Oct 30, 2023 | 28.25 | 29.23 | 28.25 | 29.00 | 810598.0 |
Oct 27, 2023 | 29.50 | 29.94 | 28.26 | 28.32 | 693846.0 |
Oct 26, 2023 | 28.48 | 29.51 | 28.11 | 29.22 | 559838.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
11.52
Minimum
Mar 16 2020
35.39
Maximum
Dec 03 2018
20.01
Average
19.16
Median
Price Benchmarks
Insmed Inc | 26.50 |
Nektar Therapeutics | 0.52 |
NeuBase Therapeutics Inc | 0.8686 |
Stoke Therapeutics Inc | 3.945 |
Mirum Pharmaceuticals Inc | 32.01 |
Price Related Metrics
PS Ratio | 379.12 |
PEG Ratio | -0.4213 |
Price to Book Value | 3.990 |
Earnings Yield | -11.12% |
Market Cap | 2.186B |
PEGY Ratio | -0.4213 |